Helmuth I G, Poulsen A, Mølbak K
Department of Paediatrics and Adolescent Medicine,Rigshospitalet,Copenhagen,Denmark.
Department of Infectious Disease Epidemiology,Statens Serum Institut,Copenhagen,Denmark.
Epidemiol Infect. 2017 Oct;145(13):2683-2693. doi: 10.1017/S0950268817001777. Epub 2017 Aug 14.
Varicella, usually a mild disease of childhood, can also cause complications and hospitalization. Universal varicella immunization is implemented in several countries worldwide, but not in Denmark. Taking advantage of unique national registers, we aimed to estimate the incidence of paediatric varicella hospitalizations and assess determinants for hospitalization. For this purpose, we designed a nationwide, retrospective register study of paediatric varicella hospitalizations and applied a case-cohort design and logistic regression analysis comparing hospitalized varicella patients to a sample of the entire paediatric population in Denmark. Varicella patients were identified in The Danish National Patient Register and referents were randomly selected from the Danish Civil Registration System. The incidence of paediatric varicella admissions was 11/100 000 children 0-18 years of age/year. Of admitted children 67·1% had complications and 30·0% had underlying disease. All categories of underlying disease significantly increased the odds of hospitalization as well as male gender and not having been born in Denmark. In conclusion, we found a considerable burden of paediatric varicella disease in Danish hospitals, of similar magnitude as in other European countries comparable to Denmark. With this study we have provided epidemiological data needed for considering implementation of varicella vaccine in Denmark.
水痘通常是一种儿童期的轻症疾病,但也可能引发并发症并导致住院治疗。全球有多个国家实施了水痘普遍免疫接种,但丹麦尚未实施。利用丹麦独特的国家登记系统,我们旨在估算儿童水痘住院的发病率,并评估住院的决定因素。为此,我们设计了一项针对儿童水痘住院情况的全国性回顾性登记研究,并采用病例队列设计和逻辑回归分析,将水痘住院患者与丹麦全体儿童样本进行比较。水痘患者通过丹麦国家患者登记系统识别,对照则从丹麦民事登记系统中随机选取。0至18岁儿童水痘住院的发病率为每年每10万名儿童中有11例。在住院儿童中,67.1%出现了并发症,30.0%有基础疾病。所有基础疾病类别以及男性性别和非在丹麦出生均显著增加了住院几率。总之,我们发现丹麦医院中儿童水痘疾病负担相当大,与丹麦类似的其他欧洲国家情况相当。通过这项研究,我们提供了在丹麦考虑实施水痘疫苗所需的流行病学数据。